24.10 III 2013 . Bristol-Myers Squibb
III 2013 . Bristol-Myers Squibb 692 . 711 . , 1,8 . C, FirstWord Pharma.
9% 4,1 ., (4 .). Yervoy, Orencia Sprycel.
Plavix, 2012 ., 42 ., 34% , 2012 .
Abilify 16% 569 ., Otsuka Pharmaceutical.
Sustiva 5%, 389 . Baraclude 9% 378 .
Orencia Reyataz 375 . . Sprycel 20% 316 ., Yervoy 33% 238 .
Bristol-Myers Squibb 1,701,78 ., (1,73 .).
